Patents by Inventor Kevin Douglas Stewart

Kevin Douglas Stewart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250170245
    Abstract: The present invention relates to stable. aqucous antibody formulations. In some embodiments, the stable, aqueous formulations comprise about 2 mg/mL to about 100 mg/mL of an anti-IL5R antibody, and about 0.002% to about 0.01% polysorbate-20. Also provided are methods of making and methods of using such antibody formulations.
    Type: Application
    Filed: February 4, 2025
    Publication date: May 29, 2025
    Inventors: William LEACH, Rachael LEWUS, James MCGIVNEY, Kelcy NEWELL, Kevin Douglas STEWART
  • Publication number: 20200297855
    Abstract: The present invention relates to stable, aqueous antibody formulations. In some embodiments, the stable, aqueous formulations comprise about 2 mg/mL to about 100 mg/mL of an anti-IL5R antibody, and about 0.002% to about 0.01% polysorbate-20. Also provided are methods of making and methods of using such antibody formulations.
    Type: Application
    Filed: March 25, 2020
    Publication date: September 24, 2020
    Inventors: William LEACH, Rachael LEWUS, James MCGIVNEY, Kelcy NEWELL, Kevin Douglas STEWART
  • Publication number: 20190201535
    Abstract: The present invention relates to stable, aqueous antibody formulations. In some embodiments, the stable, aqueous formulations comprise about 2 mg/mL to about 100 mg/mL of an anti-IL5R antibody, and about 0.002% to about 0.01% polysorbate-20. Also provided are methods of making and methods of using such antibody formulations.
    Type: Application
    Filed: March 11, 2019
    Publication date: July 4, 2019
    Inventors: William Leach, Rachael Lewus, James McGivney, Kelcy Newell, Kevin Douglas Stewart
  • Publication number: 20150118249
    Abstract: The present invention relates to stable, aqueous antibody formulations. In some embodiments, the stable, aqueous formulations comprise about 2 mg/mL to about 100 mg/mL of an anti-IL5R antibody, and about 0.002% to about 0.01% polysorbate-20. Also provided are methods of making and methods of using such antibody formulations.
    Type: Application
    Filed: October 23, 2014
    Publication date: April 30, 2015
    Inventors: William Leach, Rachael Lewus, James McGivney, Kelcy Newell, Kevin Douglas Stewart